Studies have shown that FN binding to tumor cell membrane integrins can activate downstream signaling pathways such as the integrin-linked kinase (ILK) and NF-κΒ pathways, thereby regulating the expression of EMT-related genes in lung cancer [24, 25]. This evidence concerns the gene FN1 and neoplasm.